Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen for healing of hospitalized patients with COVID-19
IRCT20200324046850N3Phase 3Completed
- Sponsor
- Abadan University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of naproxen in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Abadan University of Medical Sciences. Primary endpoint: Recovery process of patients with COVID-19. Started Apr 2020; status: completed.
02
Drugs
naproxen
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200324046850N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200324046850N3.